Detalhe da pesquisa
1.
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Nature
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588696
2.
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Mod Pathol
; 30(8): 1069-1077, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548129
3.
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 16(6): 656-66, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975632